United States · FDA National Drug Code directory
DOFETILIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-132_d9cc5e83-13c7-40a5-86d3-29216f7f55fe
- Product NDC
- 72603-132
- Form
- CAPSULE
- Composition / generic term
- DOFETILIDE
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230207
- Source listing expiry
- 20261231
Source-listed ingredients
- DOFETILIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (72603-132-01) · 72603-132-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →